BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 9663601)

  • 1. Second cancers following in situ carcinoma of the breast.
    Franceschi S; Levi F; La Vecchia C; Randimbison L; Te VC
    Int J Cancer; 1998 Jul; 77(3):392-5. PubMed ID: 9663601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive breast cancer following ductal and lobular carcinoma in situ of the breast.
    Levi F; Randimbison L; Te VC; La Vecchia C
    Int J Cancer; 2005 Sep; 116(5):820-3. PubMed ID: 15838829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of invasive cancers following carcinoma in situ of the cervix.
    Levi F; Randimbison L; La Vecchia C; Franceschi S
    Br J Cancer; 1996 Oct; 74(8):1321-3. PubMed ID: 8883426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999-2004.
    Eheman CR; Shaw KM; Ryerson AB; Miller JW; Ajani UA; White MC
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1763-9. PubMed ID: 19454615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.
    Wong SM; King T; Boileau JF; Barry WT; Golshan M
    Ann Surg Oncol; 2017 Sep; 24(9):2509-2517. PubMed ID: 28455673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The occurrence of invasive cancers following a diagnosis of breast carcinoma in situ.
    Robinson D; Holmberg L; Møller H
    Br J Cancer; 2008 Aug; 99(4):611-5. PubMed ID: 18665169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial breast carcinoma risks by morphology: a nationwide epidemiologic study from Sweden.
    Hemminki K; Granström C
    Cancer; 2002 Jun; 94(11):3063-70. PubMed ID: 12115398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology.
    Ji J; Hemminki K
    Breast Cancer Res Treat; 2007 Oct; 105(2):229-36. PubMed ID: 17115107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of invasive cancers following basal cell skin cancer.
    Levi F; La Vecchia C; Te VC; Randimbison L; Erler G
    Am J Epidemiol; 1998 Apr; 147(8):722-6. PubMed ID: 9554413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends of in situ carcinoma of the breast in Vaud, Switzerland.
    Levi F; Te VC; Randimbison L; La Vecchia C
    Eur J Cancer; 1997 May; 33(6):903-6. PubMed ID: 9291813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of invasive cancers following squamous cell skin cancer.
    Levi F; Randimbison L; La Vecchia C; Erler G; Te VC
    Am J Epidemiol; 1997 Nov; 146(9):734-9. PubMed ID: 9366621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do Body Mass Index and Breast Density Impact Cancer Risk Among Women with Lobular Carcinoma In Situ?
    Minami CA; Zabor EC; Gilbert E; Newman A; Park A; Jochelson MS; King TA; Pilewskie ML
    Ann Surg Oncol; 2020 Jun; 27(6):1844-1851. PubMed ID: 31898097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010.
    Youlden DR; Youl PH; Soyer HP; Aitken JF; Baade PD
    JAMA Dermatol; 2014 May; 150(5):526-34. PubMed ID: 25093216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer risk after radiotherapy for breast cancer.
    Levi F; Randimbison L; Te VC; La Vecchia C
    Br J Cancer; 2006 Aug; 95(3):390-2. PubMed ID: 16804519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is carcinoma in situ a precursor lesion of invasive breast cancer?
    To T; Wall C; Baines CJ; Miller AB
    Int J Cancer; 2014 Oct; 135(7):1646-52. PubMed ID: 24615647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of ipsilateral breast tumor recurrence after breast-conserving therapy.
    Jobsen J; van der Palen J; Riemersma S; Heijmans H; Ong F; Struikmans H
    Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1006-1014. PubMed ID: 25035203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland.
    Verkooijen HM; Fioretta G; Vlastos G; Morabia A; Schubert H; Sappino AP; Pelte MF; Schäfer P; Kurtz J; Bouchardy C
    Int J Cancer; 2003 May; 104(6):778-81. PubMed ID: 12640687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of contralateral second primary breast cancer according to hormone receptor status in Germany.
    Rusner C; Wolf K; Bandemer-Greulich U; Engel J; Stegmaier C; Holleczek B; Schubert-Fritschle G; Tillack A; Stang A
    Breast Cancer Res; 2014 Oct; 16(5):452. PubMed ID: 25277819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in incidence rates of invasive lobular and ductal breast carcinoma.
    Li CI; Anderson BO; Daling JR; Moe RE
    JAMA; 2003 Mar; 289(11):1421-4. PubMed ID: 12636465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.